Form 8-K - Current report:
SEC Accession No. 0001493152-24-002348
Filing Date
2024-01-16
Accepted
2024-01-16 08:30:38
Documents
15
Period of Report
2024-01-16
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 42041
2 ex99-1.htm EX-99.1 13709
3 ex99-1_001.jpg GRAPHIC 2677
  Complete submission text file 0001493152-24-002348.txt   280673

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE bfrg-20240116.xsd EX-101.SCH 3734
5 XBRL DEFINITION FILE bfrg-20240116_def.xml EX-101.DEF 26562
6 XBRL LABEL FILE bfrg-20240116_lab.xml EX-101.LAB 36578
7 XBRL PRESENTATION FILE bfrg-20240116_pre.xml EX-101.PRE 25186
9 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5081
Mailing Address 325 ELLINGTON BLVD. UNIT 317 GAITHERSBURG MD 20878
Business Address 325 ELLINGTON BLVD. UNIT 317 GAITHERSBURG MD 20878 3013672055
BullFrog AI Holdings, Inc. (Filer) CIK: 0001829247 (see all company filings)

EIN.: 844786155 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41600 | Film No.: 24533760
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)